Can a traditional tablet turn back precancerous stomach changes?

NCT ID NCT06610266

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial tests whether Weifuchun tablets can reverse gastric intestinal metaplasia, a condition where stomach lining cells change and may raise cancer risk. Adults without H. pylori infection will take Weifuchun or folic acid daily for six months, with regular checkups. The study compares how often the condition regresses or progresses in each group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Weifuchun tablet
What this could lead to
If effective, Weifuchun could offer a non-invasive way to reverse precancerous stomach changes, potentially reducing gastric cancer risk.
What could go wrong
This is a phase 4 trial, but results may not confirm benefit over folic acid, and long-term safety or effectiveness in broader populations remains uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC INTESTINAL METAPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Affiliated Hospital of Yan'an University

    RECRUITING

    Yanan, China

  • Ankang Central Hospital

    RECRUITING

    Ankang, China

  • The 986th Hospital of Air Force Medical University

    RECRUITING

    Xi'an, 710032, China

  • Tongchuan People's Hospital

    RECRUITING

    Tongchuan, China

  • Weinan Central Hospital

    RECRUITING

    Weinan, China

  • Xi'an Central Hospital

    RECRUITING

    Xi'an, China

  • Xi'an Honghui Hospital

    RECRUITING

    Xi'an, China

  • Xijing hospital

    RECRUITING

    Xi'an, 710032, China

  • Xunyang People's Hospital

    RECRUITING

    Xuchang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.